Alyeska Investment Group’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
2020
Q2
$1.14M Buy
2018
Q1
Sell
2017
Q4
$1.83M Buy
2016
Q1
Sell
2015
Q4
$569K Sell
2015
Q3
$956K Sell
2015
Q2
$1.38M Buy
2015
Q1
$404K Buy
2014
Q4
$385K Buy
2014
Q3
$263K Buy
2014
Q2
$322K Buy